Accuracy of malignant hyperthermia diagnoses in hospital discharge records

Teeda Pinyavat1, Henry Rosenberg, Barbara H Lang

  • 1From the Department of Anesthesiology, Columbia University College of Physicians and Surgeons, New York, New York (T.P., B.H.L.); Department of Medical Education and Clinical Research, Saint Barnabas Medical Center, Livingston, New Jersey (H.R.); Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (C.A.W.); Department of Anesthesiology, Toronto General Hospital, Toronto, Ontario, Canada (S.R.); Departments of Anesthesiology and Epidemiology, Columbia University College of Physicians and Surgeons and Mailman School of Public Health, New York, New York (J.E.B., G.L.); and Departments of Anesthesiology and Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York (L.S.S.).

Anesthesiology
|October 2, 2014
PubMed
Abstract

Insights

Accurate coding for malignant hyperthermia (MH) in hospital records is crucial. This study found only about a quarter of MH diagnoses represent actual MH events, with many indicating susceptibility.

Area of Science:

  • Anesthesiology
  • Medical Informatics
  • Patient Safety

Background:

  • Malignant hyperthermia (MH) coding was introduced in 1997 under the ICD-9 system.
  • Accurate coding is essential for patient safety and epidemiological studies.
  • This study aimed to assess the accuracy of MH coding in hospital discharge records.

Purpose of the Study:

  • To evaluate the accuracy of malignant hyperthermia (MH) coding in hospital discharge records.
  • To determine the proportion of coded MH diagnoses that represent actual MH events versus susceptibility or other conditions.
  • To identify factors that could improve the identification of true MH cases.

Main Methods:

  • Expert anesthesiologist panel reviewed 47 medical records with MH diagnoses (ICD-9/ICD-10).
  • Records spanned January 2006 to December 2008 from six North American tertiary care centers.
  • Cases were classified as possible, probable, or fulminant MH, MH history, or other.

Main Results:

  • Only 23.4% of coded MH diagnoses represented actual MH events.
  • MH susceptibility (personal/family history) accounted for 46.8% of cases.
  • Dantrolene was administered in 81% of MH events; all patients survived.

Conclusions:

  • Approximately 25% of coded MH diagnoses in hospital records signify incident MH episodes.
  • An additional 47% of codes relate to MH susceptibility.
  • Utilizing surgical, anesthesia, and dantrolene data can help identify true MH cases.